U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559032) titled 'Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients' on April 12.
Brief Summary: The goal of this clinical trial is to learn if amphotericin B works to treat breakthrough invasive fungal disease (IFD) in patients with hematological diseases who have received azole-based prophylaxis. It will also learn about the safety of amphotericin B in this population.
The main questions it aims to answer are:
1. What is the overall response rate (complete remission + partial remission) of amphotericin B in treating breakthrough IFD after azole prophylaxis?
2. What medical problems do participan...